Brookfield Asset Management Inc. Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Brookfield Asset Management Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Nov 16, 2022	BUY	$120.42 - $169.29 $5.42 Million - $7.62 Million	45,000 New	45,000 $6.56 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $4.73 Million - $6.65 Million	39,300 Added 689.47%	45,000 $6.56 Million
Q2 2021 Aug 17, 2021	BUY	$128.63 - $176.89 $733,191 - $1.01 Million	5,700 New	5,700 $966,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.